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OBJECTIVES: Mauritania is a highly endemic region for hepatitis B (HBV) and
delta (HDV) viruses. No data are available on HDV's impact on the severity of liver
disease in consecutive HBV-infected patients in Africa. This study evaluated the
degree of liver fibrosis in a cohort of chronic HBV carriers.
METHODS: Three-hundred consecutive HBV-infected Mauritanian patients were
checked for HDV infection via the detection of anti-HDV antibodies (Ab) and viral
RNA. HBV- vs. HBV/HDV-infected patients were compared by physical
examination, biological analyses, and the APRI (aspartate aminotransferase to
platelet ratio index) and FibroMeter tests for determination of liver fibrosis.
RESULTS: More than 30% of the patients had anti-HDVAb. Among these, 62.2%
were HDV-RNA positive. Co-infected patients were older (>8-years) than HBV-
mono-infected patients. They had more liver tests abnormalities and clinical or
ultrasound signs of liver fibrosis. APRI and FibroMeter scores were also
significantly increased in these patients. In multivariate analysis, beyond HDVAb,
male gender and HBV-VL >3.7 log IU/mL were the only markers linked to
significant liver fibrosis.
CONCLUSIONS: In Mauritania, HDV co-infection worsens liver disease, both
clinically and biologically, as confirmed by the APRI and FibroMeter tests. These
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